Administered at home by the patient or caregiver or in office by a healthcare professional
Studied alone and in combination with oral preventive treatments1
Patients who previously participated in the clinical trials of AJOVY were recruited to complete an online survey.†
When given the power to choose:
Nearly 70% of people reported that they would choose quarterly dosing instead of monthly dosing.
†253 chronic and episodic migraine patients who previously participated in clinical trials were recruited to complete an online survey. Patients, blinded as to whether they received monthly or quarterly injections of AJOVY, were asked, “Would you rather take the injectable migraine medicine as 1 injection once a month or 3 injections once every 3 months?” 69% of respondents said they’d rather take the quarterly dosing option and 31% said they’d rather take the monthly dosing option.2